Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
Conditions:   Acquired Immunodeficiency Syndrome;   Alcoholism;   HIV Infection;   Neoplasm;   Smoking
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Completed - verified July 2004
Source: clinicaltrials.gov

A Study of 1592U89 in HIV-Infected Adults
Condition:   HIV Infections
Intervention:   Drug: Abacavir sulfate
Sponsor:   Glaxo Wellcome
Completed - verified December 1998
Source: clinicaltrials.gov

A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition
Conditions:   Anorexia;   Cachexia;   HIV Infections
Intervention:   Drug: Megestrol acetate
Sponsor:   Bristol-Myers Squibb
Completed - verified October 2007
Source: clinicaltrials.gov

Leave a Comment - Popsugar

Leave a Comment - Popsugar
Tom Brady Has a Special Christmas Package Should Heidi and Spencer Get a Wedding Planning Show? Date Night For Jessica and Cash Marky Mark Steps Into Santa Land Link Time
Source: www.popsugar.com

China Sky One Medical (CSKI) Subsidiary Receives Production Approval - StreetInsider.com
China Sky One Medical, Inc. (Nasdaq: CSKI ) announced today that its subsidiary, Heilongjiang Tianlong Pharmaceutical, Inc., successfully obtained production approval from the
Source: www.streetinsider.com

FDA says ad for Abbott's Humira downplays risks - Reuters UK
WASHINGTON (Reuters) - An advertisement for Abbott Laboratories' Humira minimizes the arthritis drug's risks while suggesting it can treat a wider range of patients than it is
Source: uk.reuters.com

UPDATE 2-US FDA says ad for Abbott's Humira downplays risks - Reuters
WASHINGTON, Dec 23 (Reuters) - An advertisement for Abbott Laboratories' ( ABT.N ) Humira minimizes the arthritis drug's risks while suggesting it can treat a wider range of
Source: www.reuters.com

Provectus Pharmaceuticals Adds Seventh Center to Phase 2 Clinical - MSN MoneyCentral
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the
Source: news.moneycentral.msn.com

FDA warns Abbott over ad for psoriasis drug - Marketwatch
, , ) over an advertisement for the company's psoriasis drug Humira, saying it is misleading and makes claims not supported by scientific evidence. The ad for Humira suggests the
Source: www.marketwatch.com

Freebie Fridays Help You Save Cash - WSB-TV Atlanta

Freebie Fridays Help You Save Cash - WSB-TV Atlanta
Here's another freebie, especially useful if you overindulge on food over the Christmas holiday! Block the heartburn before it begins! click here . If you're a member of Sam's club
Source: www.wsbtv.com

Piercing developments - CNN Sports Illustrated
If the tape ain't lying, Antonio Pierce (left) has been chasing foes and women -- without much success of late. Drew Hallowell/Getty Images With the road to the Super Bowl now
Source: sportsillustrated.cnn.com

Psoriasis - Overview of Psoriasis Symptoms, Treatment and Coping

Psoriasis - Overview of Psoriasis Symptoms, Treatment and Coping
Psoriasis is a chronic skin disease suffered by millions of Americans. Proper treatment is the key to minimizing the effects of psoriasis. Learn more about the symptoms of this

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Condition:   HIV Infections
Interventions:   Drug: Nelfinavir mesylate;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Keyhole-Limpet Hemocyanin;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine
Sponsor:   Agouron Pharmaceuticals
Active, not recruiting - verified July 2002
Source: clinicaltrials.gov

Phase II Long Term, Randomized Study of Recombinant Human Insulin-Like Growth Factor I in Children With Hyperinsulinism
Condition:   Hyperinsulinism
Intervention:   Drug: insulin-like growth factor I
Sponsors:   FDA Office of Orphan Products Development;   Children's Hospital of Philadelphia
Active, not recruiting - verified March 1999
Source: clinicaltrials.gov

Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Condition:   Lung Cancer
Interventions:   Drug: docetaxel;   Drug: irinotecan hydrochloride
Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
Completed - verified July 2006
Source: clinicaltrials.gov

Outpatient Evaluation of Patients With Known or Suspected Heart Disease
Condition:   Heart Disease
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 2001
Source: clinicaltrials.gov